Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.

Alem Zekarias Sarah Watson Sara Hedfors Vidlin Birgitta Grundmark

Published in: Drug safety (2020)

Review of a global database of suspected ADR reports revealed sex differences in the reporting patterns for drugs used in the treatment of COVID-19. Patterns of ADR sex differences need further elucidation.

Keyphrases

adverse drug
coronavirus disease
sars cov
drug induced
electronic health record
emergency department
pulmonary embolism
single cell
smoking cessation